DE602004008505D1 - Modulatoren des vitamin-d-rezeptors - Google Patents
Modulatoren des vitamin-d-rezeptorsInfo
- Publication number
- DE602004008505D1 DE602004008505D1 DE602004008505T DE602004008505T DE602004008505D1 DE 602004008505 D1 DE602004008505 D1 DE 602004008505D1 DE 602004008505 T DE602004008505 T DE 602004008505T DE 602004008505 T DE602004008505 T DE 602004008505T DE 602004008505 D1 DE602004008505 D1 DE 602004008505D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- receptor modulators
- compounds
- receptor
- secosteroidal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52360003P | 2003-11-20 | 2003-11-20 | |
US523600P | 2003-11-20 | ||
PCT/US2004/037181 WO2005051940A2 (en) | 2003-11-20 | 2004-11-16 | Vitamin d receptor modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602004008505D1 true DE602004008505D1 (de) | 2007-10-04 |
DE602004008505T2 DE602004008505T2 (de) | 2008-05-21 |
Family
ID=34632799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004008505T Active DE602004008505T2 (de) | 2003-11-20 | 2004-11-16 | Modulatoren des vitamin-d-rezeptors |
Country Status (8)
Country | Link |
---|---|
US (2) | US7582775B2 (de) |
EP (1) | EP1687292B1 (de) |
JP (1) | JP4717006B2 (de) |
AT (1) | ATE370941T1 (de) |
CA (1) | CA2544522A1 (de) |
DE (1) | DE602004008505T2 (de) |
ES (1) | ES2291981T3 (de) |
WO (1) | WO2005051940A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2485503C (en) * | 2002-05-29 | 2011-07-19 | Eli Lilly And Company | Phenyl-thiophene type vitamin d receptor modulators |
EP1565422B1 (de) | 2002-11-22 | 2009-02-04 | Eli Lilly And Company | Modulatoren von vitamin d rezeptoren |
CA2544522A1 (en) * | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
ATE396982T1 (de) | 2003-11-20 | 2008-06-15 | Lilly Co Eli | Phenylfuranverbindungen als modulatoren des vitamin-d-rezeptors |
US7750184B2 (en) | 2003-11-20 | 2010-07-06 | Eli Lilly And Company | Vitamin D receptor modulators |
CA2544501A1 (en) | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
US7579488B2 (en) | 2003-11-20 | 2009-08-25 | Eli Lilly And Company | Vitamin D receptor modulators |
JP4917018B2 (ja) * | 2004-05-03 | 2012-04-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物 |
CA2589664A1 (en) * | 2004-12-21 | 2006-06-29 | Eli Lilly And Company | Vitamin d receptor modulators |
KR100931777B1 (ko) * | 2004-12-21 | 2009-12-14 | 일라이 릴리 앤드 캄파니 | 비타민 d 수용체 조절제 |
EP1676834A1 (de) | 2004-12-30 | 2006-07-05 | Sanofi-Aventis Deutschland GmbH | Kondensierte Bicyclische Carboxamid-Derivate zur Verwendung als CXCR2 Inhibitoren zur Behandlung von Entzündungen |
EP2040690B1 (de) | 2006-06-28 | 2014-08-06 | Sanofi | Cxcr2-inhibitoren |
WO2008000408A1 (en) | 2006-06-28 | 2008-01-03 | Sanofi-Aventis | Cxcr2 antagonists |
EP2040688B1 (de) | 2006-06-28 | 2014-04-02 | Sanofi | Neue cxcr2 inhibitoren |
JP5352455B2 (ja) | 2006-06-30 | 2013-11-27 | サノフイ | Cxcr2阻害剤 |
US10100015B2 (en) * | 2015-03-24 | 2018-10-16 | Shanghai Yingli Pharmaceutical Co., Ltd. | Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1137733B (de) | 1954-06-05 | 1962-10-11 | Chem Fab Promonta G M B H | Verfahren zur Herstellung von Aryl- und Thienylmethylphenylalkylaminen |
US5300499A (en) | 1992-09-02 | 1994-04-05 | Allergan, Inc. | 5-substituted 3-thiophene sulfonamides as antiglaucoma agents |
FR2742149B1 (fr) * | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | Nouveaux derives de 2-naphtamides et leurs applications therapeutiques |
CA2207141A1 (en) * | 1996-07-15 | 1998-01-15 | David Thompson Berg | Benzothiophene compounds, and uses and formulations thereof |
DE19718334A1 (de) | 1997-04-30 | 1998-11-05 | Boehringer Ingelheim Pharma | Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO1999031112A1 (de) * | 1997-12-17 | 1999-06-24 | Schering Aktiengesellschaft | Vitamin d-derivate mit phosphoratomen in den seitenketten |
US6110963A (en) * | 1998-05-12 | 2000-08-29 | American Home Products Corporation | Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
US6218430B1 (en) | 1998-08-24 | 2001-04-17 | Ligand Pharmaceuticals Incorporated | Vitamin D3 mimics |
FR2801307B1 (fr) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
CA2485503C (en) * | 2002-05-29 | 2011-07-19 | Eli Lilly And Company | Phenyl-thiophene type vitamin d receptor modulators |
EP1565422B1 (de) | 2002-11-22 | 2009-02-04 | Eli Lilly And Company | Modulatoren von vitamin d rezeptoren |
EP1587905A3 (de) * | 2003-01-10 | 2005-12-14 | Eli Lilly And Company | Vesikansbehandlung mit vitamin-d-rezeptormodulatoren des phenyl-thiophen-typs |
EP1587906A2 (de) * | 2003-01-10 | 2005-10-26 | Eli Lilly And Company | Vesikansbehandlung mit vitamin-d-rezeptormodulatoren des phenyl-phenyl-typs |
WO2005037755A2 (en) | 2003-10-14 | 2005-04-28 | X-Ceptor Therapeutics, Inc. | Bridged ring structures as pharmaceutical agents |
CA2544501A1 (en) | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
ATE396982T1 (de) * | 2003-11-20 | 2008-06-15 | Lilly Co Eli | Phenylfuranverbindungen als modulatoren des vitamin-d-rezeptors |
US7750184B2 (en) * | 2003-11-20 | 2010-07-06 | Eli Lilly And Company | Vitamin D receptor modulators |
CA2544522A1 (en) | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
US7579488B2 (en) * | 2003-11-20 | 2009-08-25 | Eli Lilly And Company | Vitamin D receptor modulators |
KR100931777B1 (ko) | 2004-12-21 | 2009-12-14 | 일라이 릴리 앤드 캄파니 | 비타민 d 수용체 조절제 |
CA2589664A1 (en) | 2004-12-21 | 2006-06-29 | Eli Lilly And Company | Vitamin d receptor modulators |
-
2004
- 2004-11-16 CA CA002544522A patent/CA2544522A1/en not_active Abandoned
- 2004-11-16 US US10/579,564 patent/US7582775B2/en not_active Expired - Fee Related
- 2004-11-16 AT AT04819516T patent/ATE370941T1/de not_active IP Right Cessation
- 2004-11-16 EP EP04819516A patent/EP1687292B1/de not_active Not-in-force
- 2004-11-16 WO PCT/US2004/037181 patent/WO2005051940A2/en active IP Right Grant
- 2004-11-16 DE DE602004008505T patent/DE602004008505T2/de active Active
- 2004-11-16 ES ES04819516T patent/ES2291981T3/es active Active
- 2004-11-16 JP JP2006541233A patent/JP4717006B2/ja not_active Expired - Fee Related
-
2009
- 2009-07-06 US US12/497,983 patent/US7897789B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1687292B1 (de) | 2007-08-22 |
CA2544522A1 (en) | 2005-06-09 |
WO2005051940A3 (en) | 2005-08-11 |
DE602004008505T2 (de) | 2008-05-21 |
US7897789B2 (en) | 2011-03-01 |
US20100076065A1 (en) | 2010-03-25 |
US20070149810A1 (en) | 2007-06-28 |
JP4717006B2 (ja) | 2011-07-06 |
ATE370941T1 (de) | 2007-09-15 |
ES2291981T3 (es) | 2008-03-01 |
JP2007512329A (ja) | 2007-05-17 |
US7582775B2 (en) | 2009-09-01 |
WO2005051940A2 (en) | 2005-06-09 |
EP1687292A2 (de) | 2006-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108988T1 (el) | Διαμορφωτες υποδοχεα βιταμινης d | |
CY1109341T1 (el) | Διαμορφωτες υποδοχεα βιταμινης d τυπου φαινυλο-θειοφαινιου | |
DE602004008505D1 (de) | Modulatoren des vitamin-d-rezeptors | |
WO2005051893A3 (en) | Vitamin d receptor modulators | |
ATE396982T1 (de) | Phenylfuranverbindungen als modulatoren des vitamin-d-rezeptors | |
ECSP066392A (de) | ||
AU2003217055A1 (en) | Protein for use in hypoxia related conditions | |
BR0309278A (pt) | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto | |
PA8493701A1 (es) | Compuestos para tratar la obesidad | |
WO2005051898A3 (en) | Vitamin d receptor modulators | |
MX2010005028A (es) | Moduladores de gamma secretasa. | |
CY1110326T1 (el) | Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους | |
DE60326272D1 (de) | Komponenten des ampk-wegs | |
WO2004063345A3 (en) | Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators | |
ATE455749T1 (de) | Verbindungen mit verbrückten ringen als pharmazeutische mittel | |
WO2004054968A3 (en) | 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol) | |
WO2005045428A3 (en) | Methods and compositions for modulating apoptosis | |
GB0517292D0 (en) | Cell migration modulating compounds | |
WO2022251212A3 (en) | Uses of a somatostatin modulator for the treatment of disease | |
WO2003105854A3 (en) | CALCIUM CHANNEL INHIBITORS BASED ON DIHYDROPYRIMIDINES, DIHYDROPYRIMIDONES AND SUBSTITUTED DIHYDROPYRIMIDINETHIONES | |
AR042422A1 (es) | Formulaciones farmaceuticas de modafinil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |